Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Clinical Application of Gut Microbiota Metabolites: A Novel Opportunity in Personalized Medicine



Hoseinitavassol Z1 ; Ejtahed HS1, 2 ; Soroush AR1 ; Shahriari A1, 3 ; Siadat SD2, 3 ; Hasaniranjbar S1 ; Nikfar S4 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
  4. 4. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Koomesh Published:2022

Abstract

Nowadays, metabolomics studies are performed with different approaches to identify biomarkers, clarify the underlying mechanisms of diseases and achieve novel treatment strategies. In this context, gut microbiota-derived metabolites are known as one of the most important mediators of gut microbiota effects on human health and various diseases. Due to the inefficiency of conventional therapies in some cases, personalized medicine is of great clinical importance. Recent studies have shown that alterations in gut microbiota metabolites like short-chain fatty acids (SCFAs), amino acids, bile acid metabolites, and choline metabolites can link gut microbiota to numerous chronic non-communicable diseases including obesity, diabetes, inflammatory bowel diseases, psychological disorders, cardiovascular diseases and cancers. Understanding the composition of gut microbiota and the relationship between its derived-metabolites and the occurrence of various diseases is necessary to achieve new clinical applications. Furthermore, potential therapeutic agents such as prebiotic supplements and next-generation probiotics, dietary interventions, antibiotics, and fecal microbiota transplantation (FMT) could be among the leading strategies for personalized medicine in prognosis, diagnosis and treatment of various diseases, via modulating the diversity and composition of gut microbiota and its metabolites. © 2022, Semnan University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Interactive Relationship Between Trp Metabolites and Gut Microbiota: The Impact on Human Pathology of Disease, Journal of Applied Microbiology (2022)
2. Main Gut Bacterial Composition Differs Between Patients With Type 1 and Type 2 Diabetes and Non-Diabetic Adults, Journal of Diabetes and Metabolic Disorders (2020)
3. Role of Microbiota-Derived Short-Chain Fatty Acids in Cancer Development and Prevention, Biomedicine and Pharmacotherapy (2021)
4. The Emerging Microbiome-Based Approaches to Ibd Therapy: From Scfas to Urolithin A, Journal of Digestive Diseases (2022)
5. Dual Role of Microbiota-Derived Short-Chain Fatty Acids on Host and Pathogen, Biomedicine and Pharmacotherapy (2022)
6. Precision Medicine Journey Through Omics Approach, Journal of Diabetes and Metabolic Disorders (2022)
7. Trimethylamine N-Oxide As a Potential Risk Factor for Non-Communicable Diseases: A Systematic Review, Endocrine# Metabolic and Immune Disorders - Drug Targets (2023)
8. The Microbiome in Precision Medicine: A New Approach to Cancer Treatment, Journal of Mazandaran University of Medical Sciences (2021)
Experts (# of related papers)
View all Related Experts
Hanieh-Sadat Ejtahed (20)
Bagher Larijani (17)
Other Related Docs
9. Targeting Tmao and Its Metabolic Pathway for Cardiovascular Diseases Treatment, Journal of Diabetes and Metabolic Disorders (2021)
10. Comparing the Effects of Live and Pasteurized Akkermansia Muciniphila on Management of Obesity and Diabetes, Journal of Mazandaran University of Medical Sciences (2021)
11. The Association of Dietary Nitrates/Nitrites Intake and the Gut Microbial Metabolite Trimethylamine N-Oxide and Kynurenine in Adults: A Population-Based Study, Frontiers in Nutrition (2024)
12. Gut Microbiota: A Perspective of Precision Medicine in Endocrine Disorders, Journal of Diabetes and Metabolic Disorders (2020)
13. Microbiota Research in Iran; Current Knowledge and Future Perspective, Journal of Diabetes and Metabolic Disorders (2021)
14. Shedding Light on Biological Sex Differences and Microbiota–Gut–Brain Axis: A Comprehensive Review of Its Roles in Neuropsychiatric Disorders, Biology of Sex Differences (2022)
15. Role of Microbiota-Derived Short-Chain Fatty Acids in Nervous System Disorders, Biomedicine and Pharmacotherapy (2021)
16. Gut Microbiota Modulation As a Possible Mediating Mechanism for Fasting-Induced Alleviation of Metabolic Complications: A Systematic Review, Nutrition and Metabolism (2021)
17. Beneficial Effects of L-Carnitine Supplementation for Weight Management in Overweight and Obese Adults: An Updated Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials, Pharmacological Research (2020)
18. Our Little Friends With Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)
19. Probiotics Supplementation for the Obesity Management; a Systematic Review of Animal Studies and Clinical Trials, Journal of Functional Foods (2019)
20. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Archives of Medical Research (2020)
21. Neuromodulatory Effect of Microbiome on Gut-Brain Axis; New Target for Obesity Drugs, Journal of Diabetes and Metabolic Disorders (2019)
22. Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics, Current Nutrition Reports (2024)
23. Characterization of Gut Microbiota Profile in Iranian Patients With Bipolar Disorder Compared to Healthy Controls, Frontiers in Cellular and Infection Microbiology (2023)
24. Multidimensional Perspective of Obesity; Prevention to Treatment, Journal of Diabetes and Metabolic Disorders (2021)
25. Serum Levels of Trimethylamine N-Oxide and Kynurenine Novel Biomarkers Are Associated With Adult Metabolic Syndrome and Its Components: A Case-Control Study From the Tec Cohort, Frontiers in Nutrition (2024)
26. The Role of Gut Microbiota-Brain Axis in Pathophysiology of Adhd: A Systematic Review, Journal of Attention Disorders (2022)
27. Worldwide Trends in Scientific Publications on Association of Gut Microbiota With Obesity, Iranian Journal of Basic Medical Sciences (2019)
28. Gut Microbiota Composition in Obese and Normal Weight Adults in Iran, Journal of Mazandaran University of Medical Sciences (2021)
29. Probiotics As a New Regulator for Bone Health: A Systematic Review and Meta-Analysis, Evidence-based Complementary and Alternative Medicine (2021)
30. Targeting Obesity Management Through Gut Microbiota Modulation by Herbal Products: A Systematic Review, Complementary Therapies in Medicine (2019)
31. Immunosuppressive Effects of Two Probiotics, Lactobacillus Paracasei Dsm 13434 and Lactobacillus Plantarum Dsm 15312, on Cd4+ T Cells of Multiple Sclerosis Patients, Iranian Journal of Allergy# Asthma and Immunology (2023)
32. Metformin Induces Weight Loss Associated With Gut Microbiota Alteration in Non-Diabetic Obese Women: A Randomized Double-Blind Clinical Trial, European Journal of Endocrinology (2019)
33. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)
34. Ethical Challenges in Conducting and the Clinical Application of Human Microbiome Research, Journal of Medical Ethics and History of Medicine (2023)